Clinical Trial Update: The Plasma Large-Volume Exchange RCT [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial of plasma exchange for thrombotic thrombocytopenic purpura and hemolytic uremic syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Uremic Syndrome
• Thrombotic Thrombocytopenic Purpura

Snippet

Sponsor: London Health Sciences Centre | Conditions: Purpura, Thrombotic Thrombocytopenic, Hemolytic Uremic Syndrome | Phase 3 | Status: WITHDRAWN